01 /What it is
Anamorelin is a synthetic, orally available ghrelin receptor agonist developed in the late 2000s. It has moved through later stage research programs and is a reference compound in ghrelin receptor pharmacology.
02 /How it works
In research models, Anamorelin is studied as a selective agonist at the ghrelin (GHS-R1a) receptor. Its profile is investigated for sustained receptor engagement following oral administration.
03 /What researchers explore it for
Researchers have explored Anamorelin in ghrelin receptor research, in oral bioavailability research, and in growth hormone axis research alongside peptide GHRPs.
04 /Safety and interactions
Research interactions of note include co administration with GHRH analogs and other ghrelin receptor agonists. Anamorelin is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Compound family: orally available ghrelin receptor agonists. Frequently compared with MK-677 (Ibutamoren) and Tabimorelin. The Apothify library lists Anamorelin for encyclopedia coverage only.
Related peptides
MK-677 (Ibutamoren) · Tabimorelin · Ipamorelin